{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:41Z","timestamp":1792788101555,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration","award":["UM1DA049406"],"award-info":[{"award-number":["UM1DA049406"]}],"id":[{"id":"https:\/\/ror.org\/03t3qg659","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Care navigators are increasingly incorporated into medication for opioid use disorder (MOUD) treatment programs to address barriers to care and support patient engagement and retention. Prior research has largely focused on patient outcomes or program effectiveness, with limited attention to how frontline staff experience the integration of care navigators into routine treatment workflows. This study aimed to examine staff perceptions of care navigator roles and identify organizational and policy-relevant factors influencing their implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a qualitative study of staff perceptions of care navigators embedded in medication for opioid use disorder treatment centers participating in the HEALing Communities Study in Kentucky, USA. Semi-structured interviews were conducted with clinical and administrative staff working in participating treatment centers. Interviews explored experiences with care navigator integration, perceived impacts on patient engagement and team functioning, and implementation challenges. Data were analyzed using thematic analysis guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and the Practical, Robust Implementation and Sustainability Model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Staff described care navigators as filling critical service gaps by helping patients address practical challenges that commonly disrupt treatment engagement, including transportation barriers, housing instability, and navigating health and social services. These efforts were viewed as supporting sustained engagement in treatment with medication for opioid use disorder. Participants also reported improved team morale and reduced burnout following care navigator integration. However, staff identified persistent implementation challenges, including unclear role boundaries, scheduling constraints, and misalignment between organizational cultures. Clear differentiation between care navigators, targeted case managers, and peer support specialists was consistently identified as necessary to support effective collaboration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings suggest that care navigators may enhance engagement and workforce capacity in medication for opioid use disorder treatment settings, particularly when focused on addressing practical barriers to care. At the same time, variability in role definition and organizational fit limited effectiveness in some settings. These results highlight the importance of clear role delineation, stable funding, and implementation planning when integrating non-clinical navigation roles. Future research should incorporate patient perspectives and examine how policy and organizational contexts shape implementation and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/ClinicalTrials.gov\" ext-link-type=\"uri\">ClinicalTrials.gov<\/jats:ext-link>\n                      Identifier: NCT04111939 (registered March 26, 2019).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-026-00743-4","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:46:53Z","timestamp":1782564413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staff perceptions of care navigators in medication for opioid use disorder treatment settings"],"prefix":"10.1186","volume":"21","author":[{"given":"Michael","family":"Goetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaquita","family":"Andrews-Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Back-Haddix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0137-9337","authenticated-orcid":false,"given":"Hannah K.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"743_CR1","unstructured":"Kentucky Injury Prevention and Research Center. 2024 Drug Overdose Fatality Report. Kentucky Office of Drug Control Policy; 2025."},{"key":"743_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). CDC WONDER: Provisional drug overdose death counts. 2023."},{"key":"743_CR3","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.drugalcdep.2020.108325","volume":"217","author":"T Winhusen","year":"2020","unstructured":"Winhusen T, et al. The opioid-overdose reduction continuum of care approach (ORCCA): evidence-based practices in the HEALing communities study. Drug Alcohol Depend. 2020;217:108325.","journal-title":"Drug Alcohol Depend"},{"key":"743_CR4","unstructured":"Substance Abuse and Mental Health Services Administration [SAMHSA]. TIP 63: Medications for Opioid Use Disorder. Rockville, MD; 2021."},{"issue":"3","key":"743_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pec.2016.10.014","volume":"100","author":"SF Ali-Faisal","year":"2017","unstructured":"Ali-Faisal SF, et al. The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials. Patient Educ Couns. 2017;100(3):436\u201348.","journal-title":"Patient Educ Couns"},{"issue":"18","key":"743_CR6","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/healthcare12181814","volume":"12","author":"L Howitt","year":"2024","unstructured":"Howitt L, et al. Navigation Support during Transitions in Care for Persons with Complex Care Needs: A Systematic Review. Healthcare. 2024;12(18):1814.","journal-title":"Healthcare"},{"key":"743_CR7","doi-asserted-by":"publisher","first-page":"105888","DOI":"10.1016\/j.cct.2019.105888","volume":"87","author":"G Cochran","year":"2019","unstructured":"Cochran G, et al. A pilot multisite study of patient navigation for pregnant women with opioid use disorder. Contemp Clin Trials. 2019;87:105888.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"743_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12913-018-2889-0","volume":"18","author":"N Carter","year":"2018","unstructured":"Carter N, et al. Navigation delivery models and roles of navigators in primary care: a scoping literature review. BMC Health Serv Res. 2018;18(1):96.","journal-title":"BMC Health Serv Res"},{"key":"743_CR9","volume-title":"Medications for Opioid Use Disorder Linkage and Retention Care Navigator Training Manual","author":"HEALing Communities Study Kentucky and Bluegrass Care Navigators","year":"2023","unstructured":"HEALing Communities Study Kentucky and Bluegrass Care Navigators. Medications for Opioid Use Disorder Linkage and Retention Care Navigator Training Manual. Kentucky: Lexington; 2023."},{"issue":"3","key":"743_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.annemergmed.2022.09.025","volume":"81","author":"ES Anderson","year":"2023","unstructured":"Anderson ES, et al. Effectiveness of Substance Use Navigation for Emergency Department Patients With Substance Use Disorders: An Implementation Study. Ann Emerg Med. 2023;81(3):297\u2013308.","journal-title":"Ann Emerg Med"},{"key":"743_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/SAR.S192045","volume":"10","author":"CJ Banta-Green","year":"2019","unstructured":"Banta-Green CJ, et al. Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study. Subst Abuse Rehabil. 2019;10:57\u201367.","journal-title":"Subst Abuse Rehabil"},{"key":"743_CR12","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.dadr.2022.100031","volume":"2","author":"CD Nordeck","year":"2022","unstructured":"Nordeck CD, et al. Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug Alcohol Depend Rep. 2022;2:100031.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"12","key":"743_CR13","doi-asserted-by":"publisher","first-page":"e1462","DOI":"10.1200\/JOP.19.00314","volume":"16","author":"M Simon","year":"2020","unstructured":"Simon M, et al. Systematic Patient Navigation Strategies to Scale Breast Cancer Disparity Reduction by Improved Cancer Prevention and Care Delivery Processes. JCO Oncol Pract. 2020;16(12):e1462\u201370.","journal-title":"JCO Oncol Pract"},{"key":"743_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijnurstu.2019.05.016","volume":"98","author":"KJ Kelly","year":"2019","unstructured":"Kelly KJ, Doucet S, Luke A. Exploring the roles, functions, and background of patient navigators and case managers: A scoping review. Int J Nurs Stud. 2019;98:27\u201347.","journal-title":"Int J Nurs Stud"},{"key":"743_CR15","doi-asserted-by":"publisher","first-page":"108335","DOI":"10.1016\/j.drugalcdep.2020.108335","volume":"217","author":"SL Walsh","year":"2020","unstructured":"Walsh SL, et al. The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug Alcohol Depend. 2020;217:108335.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"743_CR16","doi-asserted-by":"publisher","first-page":"e059328","DOI":"10.1136\/bmjopen-2021-059328","volume":"12","author":"AM Young","year":"2022","unstructured":"Young AM, et al. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio. BMJ Open. 2022;12(9):e059328.","journal-title":"BMJ Open"},{"key":"743_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","volume":"7","author":"RE Glasgow","year":"2019","unstructured":"Glasgow RE, et al. RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review. Front Public Health. 2019;7:64.","journal-title":"Front Public Health"},{"issue":"9","key":"743_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322\u20137.","journal-title":"Am J Public Health"},{"key":"743_CR19","doi-asserted-by":"publisher","first-page":"108330","DOI":"10.1016\/j.drugalcdep.2020.108330","volume":"217","author":"HK Knudsen","year":"2020","unstructured":"Knudsen HK, et al. Model and approach for assessing implementation context and fidelity in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108330.","journal-title":"Drug Alcohol Depend"},{"key":"743_CR20","doi-asserted-by":"publisher","first-page":"160940692311659","DOI":"10.1177\/16094069231165933","volume":"22","author":"AS McAlearney","year":"2023","unstructured":"McAlearney AS, et al. Embedding Big Qual and Team Science Into Qualitative Research: Lessons From a Large-Scale, Cross-Site Research Study. Int J Qualitative Methods. 2023;22:16094069231165933.","journal-title":"Int J Qualitative Methods"},{"issue":"2","key":"743_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"8","key":"743_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/0142159X.2020.1755030","volume":"42","author":"ME Kiger","year":"2020","unstructured":"Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE Guide 131. Med Teach. 2020;42(8):846\u201354.","journal-title":"Med Teach"},{"key":"743_CR23","unstructured":"Jadovich E, Davis J, Andrews-Higgins S, Back-Haddix S, Goetz M, Kim E, Mayotte C, Voss L, Walker D, Beers D, Dsouza N, McAlearney AS, Rivera D, Knudsen HK, Drainoni M. We have a moral commitment to the community to sustain it: Exploring determinants of strategy sustainment after the HEALing Communities Study. Implementation Research and Practice, In press."},{"issue":"6","key":"743_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"743_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10488-015-0670-9","volume":"43","author":"KC Brimhall","year":"2016","unstructured":"Brimhall KC, et al. Leadership, Organizational Climate, and Perceived Burden of Evidence-Based Practice in Mental Health Services. Adm Policy Ment Health. 2016;43(5):629\u201339.","journal-title":"Adm Policy Ment Health"},{"issue":"2","key":"743_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/wps.20311","volume":"15","author":"C Maslach","year":"2016","unstructured":"Maslach C, Leiter MP. Understanding the burnout experience: recent research and its implications for psychiatry. World Psychiatry. 2016;15(2):103\u201311.","journal-title":"World Psychiatry"},{"key":"743_CR27","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.dadr.2023.100152","volume":"7","author":"E Adeniran","year":"2023","unstructured":"Adeniran E, et al. A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care. Drug Alcohol Depend Rep. 2023;7:100152.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"26","key":"743_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter ME. What Is Value in Health Care? N Engl J Med. 2010;363(26):2477\u201381.","journal-title":"N Engl J Med"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00743-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:14Z","timestamp":1790164934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13011-026-00743-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1186\/s13011-026-00743-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Advarra Inc. (Protocol #Pro00038088), the single Institutional Review Board for the HEALing Communities Study, and was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants provided informed consent prior to participation. Participation was voluntary, and confidentiality protections were maintained throughout data collection and analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michael Goetz, Hannah K. Knudsen, Shaquita Andrews-Higgins, Olivia Davis, Sandra Back-Haddix, and Laura Fanucchi declare that they have no competing interests. Michelle R. Lofwall has served as a research consultant for Braeburn Pharmaceuticals, Berkshire Biomedical, and Journey Colab, and has received a speaker honorarium for an invited research talk from Camurus. Sharon L. Walsh has served as a scientific advisor to Cerevel Therapeutics, AstraZeneca, Kinoxis, Reacx, Titan, Indivior, and Braeburn Pharmaceuticals.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"60"}}